Jiang TT - Search Results

1

Imaging Manifestation of Adenoid Cystic Carcinoma of the Breast.

Tang W, Peng WJ, Gu YJ, Zhu H, Jiang TT, Li C. Tang W, et al. Among authors: jiang tt. J Comput Assist Tomogr. 2015 Jul-Aug;39(4):523-30. doi: 10.1097/RCT.0000000000000236. J Comput Assist Tomogr. 2015. PMID: 25836024

2

Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia.

Feng L, Li J, Yang L, Zhu L, Huang X, Zhang S, Luo L, Jiang Z, Jiang T, Xu W, Wang X, Jin H. Feng L, et al. Theranostics. 2017 Apr 10;7(7):1890-1900. doi: 10.7150/thno.19135. eCollection 2017. Theranostics. 2017. PMID: 28638475 Free PMC article.

3

EGFR TKIs impair lysosome-dependent degradation of SQSTM1 to compromise the effectiveness in lung cancer.

Yang L, Ying S, Hu S, Zhao X, Li M, Chen M, Zhu Y, Song P, Zhu L, Jiang T, An H, Yousafzai NA, Xu W, Zhang Z, Wang X, Feng L, Jin H. Yang L, et al. Signal Transduct Target Ther. 2019 Jul 12;4:25. doi: 10.1038/s41392-019-0059-4. eCollection 2019. Signal Transduct Target Ther. 2019. PMID: 31637005 Free PMC article.

4

Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies.

Chen M, Hu S, Li Y, Jiang TT, Jin H, Feng L. Chen M, et al. Among authors: jiang tt. Signal Transduct Target Ther. 2020 Nov 20;5(1):270. doi: 10.1038/s41392-020-00347-9. Signal Transduct Target Ther. 2020. PMID: 33214545 Free PMC article. Review.

5

A combined model using pre-treatment CT radiomics and clinicopathological features of non-small cell lung cancer to predict major pathological responses after neoadjuvant chemoimmunotherapy.

Wang F, Yang H, Chen W, Ruan L, Jiang T, Cheng L, Jiang H, Fang M. Wang F, et al. Curr Probl Cancer. 2024 Jun;50:101098. doi: 10.1016/j.currproblcancer.2024.101098. Epub 2024 May 4. Curr Probl Cancer. 2024. PMID: 38704949

6

Silencing Artemis Enhances Colorectal Cancer Cell Sensitivity to DNA-Damaging Agents.

Liu H, Wang X, Huang A, Gao H, Sun Y, Jiang T, Shi L, Wu X, Dong Q, Sun X. Liu H, et al. Oncol Res. 2018 Dec 27;27(1):29-38. doi: 10.3727/096504018X15179694020751. Epub 2018 Feb 9. Oncol Res. 2018. PMID: 29426373 Free PMC article.

7

Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer.

Zhu L, Zhu Y, Han S, Chen M, Song P, Dai D, Xu W, Jiang T, Feng L, Shin VY, Wang X, Jin H. Zhu L, et al. Cell Death Dis. 2019 May 16;10(6):383. doi: 10.1038/s41419-019-1585-2. Cell Death Dis. 2019. PMID: 31097692 Free PMC article.

8

Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.

Li J, Song P, Jiang T, Dai D, Wang H, Sun J, Zhu L, Xu W, Feng L, Shin VY, Morrison H, Wang X, Jin H. Li J, et al. Mol Ther. 2018 Jul 5;26(7):1828-1839. doi: 10.1016/j.ymthe.2018.04.014. Epub 2018 Apr 14. Mol Ther. 2018. PMID: 29730197 Free PMC article.

9

Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha.

Zhang S, Jiang T, Feng L, Sun J, Lu H, Wang Q, Pan M, Huang D, Wang X, Wang L, Jin H. Zhang S, et al. J Mol Med (Berl). 2012 Sep;90(9):1069-77. doi: 10.1007/s00109-012-0879-y. Epub 2012 Mar 6. J Mol Med (Berl). 2012. PMID: 22391813

10

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair.

Liu H, Yang W, Gao H, Jiang T, Gu B, Dong Q, Xu W, Wu S, Sun X. Liu H, et al. Onco Targets Ther. 2015 Feb 25;8:509-18. doi: 10.2147/OTT.S76958. eCollection 2015. Onco Targets Ther. 2015. PMID: 25750543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters